The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-30), Gossamer Bio's share price is $0.6963. Gossamer Bio's Book Value per Share for the quarter that ended in Dec. 2023 was $0.28. Hence, Gossamer Bio's PB Ratio of today is 2.50.
The historical rank and industry rank for Gossamer Bio's PB Ratio or its related term are showing as below:
GOSS'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 35.31
Current: 2.49
During the past 8 years, Gossamer Bio's highest PB Ratio was 35.31. The lowest was 0.00. And the median was 0.00.
GOSS's PB Ratio is ranked worse than 50.46% of 1310
companies
in the Biotechnology industry
Industry Median: 2.375
vs GOSS: 2.49
During the past 12 months, Gossamer Bio's average Book Value Per Share Growth Rate was 117.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -60.00% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Gossamer Bio was -60.00% per year. The lowest was -71.80% per year. And the median was -65.90% per year.
Back to Basics: PB Ratio
Gossamer Bio PB Ratio Historical Data
The historical data trend for Gossamer Bio's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Gossamer Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gossamer Bio's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gossamer Bio's PB Ratio distribution charts can be found below:
* The bar in red indicates where Gossamer Bio's PB Ratio falls into.
Gossamer Bio PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Gossamer Bio's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Gossamer Bio PB Ratio Related Terms
Thank you for viewing the detailed overview of Gossamer Bio's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GOSS has been successfully added to your 